The DOI matches its Crossref record; 88 of the 88 references it cites were found in a registry or an index.
Lung Cancer Staging and Prognosis
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2017) · Springer eBooks · doi:10.1007/978-3-319-40618-3 · Cited by 17,242
TNM Classification of Malignant Tumours
(1987) · Springer eBooks · doi:10.1007/978-3-642-82982-6 · Cited by 16,049
The blockade of immune checkpoints in cancer immunotherapy
Pardoll, D. M. (2012) · Nature Reviews Cancer · doi:10.1038/nrc3239 · Cited by 13,838
Safety, activity, and immune correlates of anti–PD-1 antibody in cancer
Topalian, S. L., Hodi, F. S., Brahmer, J. R., Gettinger, S. N., Smith, D. C., McDermott, D. F., Powderly, J. D., Carvajal, R. D., Sosman, J. A., Atkins, M. B., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1200690 · Cited by 12,628
Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer
Brahmer, J., Reckamp, K. L., Baas, P., Crinò, L., Eberhardt, W. E. E., Poddubskaya, E., Antonia, S., Pluzanski, A., Vokes, E. E., Holgado, E., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1504627 · Cited by 8,447
Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer
Garon, E. B., Rizvi, N. A., Hui, R., Leighl, N., Balmanoukian, A. S., Eder, J. P., Patnaik, A., Aggarwal, C., Gubens, M., Horn, L., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1501824 · Cited by 6,198
Egner, J. R. (2010) · JAMA · doi:10.1001/jama.2010.1525 · Cited by 5,997
Goldstraw, P., Crowley, J., Chansky, K., Giroux, D. J., Groome, P. A., Rami-Porta, R., Postmus, P. E., Rusch, V., & Sobin, L. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812f3c1a · Cited by 3,655
PD-L1 expression as a predictive biomarker in cancer immunotherapy
Patel, S. P., & Kurzrock, R. (2015) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-14-0983 · Cited by 2,291
Govindan, R., Page, N., Morgensztern, D., Read, W., Tierney, R., Vlahiotis, A., Spitznagel, E. L., & Piccirillo, J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.4859 · Cited by 1,845
Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
Winton, T., Livingston, R., Johnson, D., Rigas, J., Johnston, M., Butts, C., Cormier, Y., Goss, G., Inculet, R., Vallieres, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043623 · Cited by 1,810
DNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
Olaussen, K. A., Dunant, A., Fouret, P., Brambilla, E., André, F., Haddad, V., Taranchon, E., Filipits, M., Pirker, R., Popper, H. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060570 · Cited by 1,727
Detection of Mutations in EGFR in Circulating Lung-Cancer Cells
Maheswaran, S., Sequist, L. V., Nagrath, S., Ulkus, L., Brannigan, B., Collura, C. V., Inserra, E., Diederichs, S., Iafrate, A. J., Bell, D. W., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0800668 · Cited by 1,617
Postmus, P. E., Brambilla, E., Chansky, K., Crowley, J., Goldstraw, P., Patz, E. F., & Yokomise, H. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31811f4703 · Cited by 1,594
Douillard, J.-Y., Rosell, R., De Lena, M., Carpagnano, F., Ramlau, R., Gonzáles-Larriba, J. L., Grodzki, T., Pereira, J. R., Le Groumellec, A., Lorusso, V., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70804-x · Cited by 1,573
Eberhard, D. A., Johnson, B. E., Amler, L. C., Goddard, A. D., Heldens, S. L., Herbst, R. S., Ince, W. L., Jänne, P. A., Januario, T., Johnson, D. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.857 · Cited by 1,461
Martini, N., & Melamed, M. R. (1975) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/s0022-5223(19)40289-4 · Cited by 1,305
Activation of the PD-1 Pathway Contributes to Immune Escape in EGFR-Driven Lung Tumors
Akbay, E. A., Koyama, S., Carretero, J., Altabef, A., Tchaicha, J. H., Christensen, C. L., Mikse, O. R., Cherniack, A. D., Beauchamp, E. M., Pugh, T. J., et al. (2013) · Cancer Discovery · doi:10.1158/2159-8290.cd-13-0310 · Cited by 1,231
Rusch, V. W., Asamura, H., Watanabe, H., Giroux, D. J., Rami-Porta, R., & Goldstraw, P. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181a0d82e · Cited by 1,209
Gettinger, S. N., Horn, L., Gandhi, L., Spigel, D. R., Antonia, S. J., Rizvi, N. A., Powderly, J. D., Heist, R. S., Carvajal, R. D., Jackman, D. M., et al. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.58.3708 · Cited by 1,177
Lynch, T. J., Bondarenko, I., Luft, A., Serwatowski, P., Barlesi, F., Chacko, R., Sebastian, M., Neal, J., Lu, H., Cuillerot, J.-M., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2011.38.4032 · Cited by 1,002
Xu, Y., Liu, H., Chen, J., & Zhou, Q. (2010) · Thoracic Cancer · doi:10.1111/j.1759-7714.2010.00016.x · Cited by 884
The New Lung Cancer Staging System
Detterbeck, F. C., Boffa, D. J., & Tanoue, L. T. (2009) · Chest · doi:10.1378/chest.08-0978 · Cited by 817
Parsons, A., Daley, A., Begh, R., & Aveyard, P. (2010) · BMJ · doi:10.1136/bmj.b5569 · Cited by 696
The Influence of Hospital Volume on Survival after Resection for Lung Cancer
Bach, P. B., Cramer, L. D., Schrag, D., Downey, R. J., Gelfand, S. E., & Begg, C. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200107193450306 · Cited by 693
Travis, W. D. (2002) · Clinics in Chest Medicine · doi:10.1016/s0272-5231(03)00061-3 · Cited by 655
Azuma, K., Ota, K., Kawahara, A., Hattori, S., Iwama, E., Harada, T., Matsumoto, K., Takayama, K., Takamori, S., Kage, M., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu242 · Cited by 645
Rami-Porta, R., Ball, D., Crowley, J., Giroux, D. J., Jett, J., Travis, W. D., Tsuboi, M., Vallières, E., & Goldstraw, P. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31807a2f81 · Cited by 637
Groome, P. A., Bolejack, V., Crowley, J. J., Kennedy, C., Krasnik, M., Sobin, L. H., & Goldstraw, P. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31812d05d5 · Cited by 613
Shepherd, F. A., Crowley, J., Van Houtte, P., Postmus, P. E., Carney, D., Chansky, K., Shaikh, Z., & Goldstraw, P. (2007) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31815bdc0d · Cited by 548
Travis, W. D. (2011) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2011.08.005 · Cited by 520
Zhu, C.-Q., Ding, K., Strumpf, D., Weir, B. A., Meyerson, M., Pennell, N., Thomas, R. K., Naoki, K., Ladd-Acosta, C., Liu, N., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.26.4325 · Cited by 471
Punnoose, E. A., Atwal, S., Liu, W., Raja, R., Fine, B. M., Hughes, B. G. M., Hicks, R. J., Hampton, G. M., Amler, L. C., Pirzkall, A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3148 · Cited by 415
Der, S. D., Sykes, J., Pintilie, M., Zhu, C.-Q., Strumpf, D., Liu, N., Jurisica, I., Shepherd, F. A., & Tsao, M.-S. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000042 · Cited by 372
ERCC1 Isoform Expression and DNA Repair in Non–Small-Cell Lung Cancer
Friboulet, L., Olaussen, K. A., Pignon, J.-P., Shepherd, F. A., Tsao, M.-S., Graziano, S., Kratzke, R., Douillard, J.-Y., Seymour, L., Pirker, R., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1214271 · Cited by 371
Rami-Porta, R., Bolejack, V., Giroux, D. J., Chansky, K., Crowley, J., Asamura, H., & Goldstraw, P. (2014) · Journal of Thoracic Oncology · doi:10.1097/jto.0000000000000334 · Cited by 367
Lung Cancer Incidence Trends by Gender, Race and Histology in the United States, 1973–2010
Meza, R., Meernik, C., Jeon, J., & Cote, M. L. (2015) · PLOS ONE · doi:10.1371/journal.pone.0121323 · Cited by 363
Kratz, J. R., He, J., Van Den Eeden, S. K., Zhu, Z.-H., Gao, W., Pham, P. T., Mulvihill, M. S., Ziaei, F., Zhang, H., Su, B., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61941-7 · Cited by 333
Self-citationA SYSTEM FOR THE CLINICAL STAGING OF LUNG CANCER
MOUNTAIN, C. F., CARR, D. T., & ANDERSON, W. A. D. (1974) · American Journal of Roentgenology · doi:10.2214/ajr.120.1.130 · Cited by 327
Shepherd, F. A., Domerg, C., Hainaut, P., Jänne, P. A., Pignon, J.-P., Graziano, S., Douillard, J.-Y., Brambilla, E., Le Chevalier, T., Seymour, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.1390 · Cited by 293
Tang, H., Xiao, G., Behrens, C., Schiller, J., Allen, J., Chow, C.-W., Suraokar, M., Corvalan, A., Mao, J., White, M. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-2321 · Cited by 284
A Prognostic DNA Methylation Signature for Stage I Non–Small-Cell Lung Cancer
Sandoval, J., Mendez-Gonzalez, J., Nadal, E., Chen, G., Carmona, F. J., Sayols, S., Moran, S., Heyn, H., Vizoso, M., Gomez, A., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.48.5516 · Cited by 278
Travis, W. D., Giroux, D. J., Chansky, K., Crowley, J., Asamura, H., Brambilla, E., Jett, J., Kennedy, C., Rami-Porta, R., Rusch, V. W., et al. (2008) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31818b06e3 · Cited by 273
Bejarano, P. A. (2011) · Yearbook of Pathology and Laboratory Medicine · doi:10.1016/s1077-9108(10)79482-2 · Cited by 273
The prognostic value of PD-L1 expression for non-small cell lung cancer patients: A meta-analysis
Wang, A., Wang, H. Y., Liu, Y., Zhao, M. C., Zhang, H. J., Lu, Z. Y., Fang, Y. C., Chen, X. F., & Liu, G. T. (2015) · European Journal of Surgical Oncology (EJSO) · doi:10.1016/j.ejso.2015.01.020 · Cited by 255
Kosaka, T., Yatabe, Y., Onozato, R., Kuwano, H., & Mitsudomi, T. (2009) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181914111 · Cited by 254
Tang, Y., Fang, W., Zhang, Y., Hong, S., Kang, S., Yan, Y., Chen, N., Zhan, J., He, X., Qin, T., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.3694 · Cited by 243
Special Treatment Issues in Lung Cancer
Shen, K. R., Meyers, B. F., Larner, J. M., & Jones, D. R. (2007) · Chest · doi:10.1378/chest.07-1382 · Cited by 237
Staging manual in thoracic oncology
Goldstraw, P. G. (2009) · Medical Entomology and Zoology · Cited by 226
Ou, S. ‐. I., Zell, J. A., Ziogas, A., & Anton‐Culver, H. (2007) · Cancer · doi:10.1002/cncr.22938 · Cited by 222
High MET Gene Copy Number Leads to Shorter Survival in Patients with Non-small Cell Lung Cancer
Go, H., Jeon, Y. K., Park, H. J., Sung, S.-W., Seo, J.-W., & Chung, D. H. (2010) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3181ce3d1d · Cited by 218
Small cell lung cancer: state of the art and future perspectives
Stupp, R., Monnerat, C., Turrisi, A. T., Perry, M. C., & Leyvraz, S. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2003.12.006 · Cited by 163
Chen, V. W., Ruiz, B. A., Hsieh, M., Wu, X., Ries, L. A. G., & Lewis, D. R. (2014) · Cancer · doi:10.1002/cncr.29045 · Cited by 161
Ha, S. Y., Choi, S.-J., Cho, J. H., Choi, H. J., Lee, J., Jung, K., Irwin, D., Liu, X., Lira, M. E., Mao, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.2925 · Cited by 161
Warth, A., Cortis, J., Soltermann, A., Meister, M. A., Budczies, J., Stenzinger, A., Goeppert, B. F., Thomas, M., Herth, F. J. F., Schirmacher, P., et al. (2014) · British Journal of Cancer · doi:10.1038/bjc.2014.402 · Cited by 161
Zhai, R., Yu, X., Shafer, A., Wain, J. C., & Christiani, D. C. (2013) · CHEST Journal · doi:10.1378/chest.13-1176 · Cited by 157
Sun, Z., Aubry, M.-C., Deschamps, C. C., Marks, R. S., Okuno, S. H., Williams, B. A., Sugimura, H., Pankratz, V. S., & Yang, P. (2006) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2005.12.057 · Cited by 148
ELIAS, A. D. (1997) · CHEST Journal · doi:10.1378/chest.112.4_supplement.251s · Cited by 135
Salvi, S., Fontana, V., Boccardo, S., Merlo, D. F., Margallo, E., Laurent, S., Morabito, A., Rijavec, E., Dal Bello, M. G., Mora, M., et al. (2012) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-012-1211-y · Cited by 133
Prognosis in advanced lung cancer – A prospective study examining key clinicopathological factors
Simmons, C. P. L., Koinis, F., Fallon, M., Fearon, K. C. H., Bowden, J., Solheim, T. S., Grønberg, B. H., McMillan, D. C., Gioulbasanis, I., & Laird, B. J. A. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.03.020 · Cited by 130
Dziadziuszko, R., Merrick, D. T., Witta, S. E., Mendoza, A. D., Szostakiewicz, B., Szymanowska, A., Rzyman, W., Dziadziuszko, K., Jassem, J., Bunn, P. A., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.6611 · Cited by 128
Huang, J., Wang, K., Xu, J., Huang, J., & Zhang, T. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078070 · Cited by 123
Immunotherapy in the treatment of non-small cell lung cancer
Sundar, R., Soong, R., Cho, B. C., Brahmer, J. R., & Soo, R. A. (2014) · Lung Cancer · doi:10.1016/j.lungcan.2014.05.005 · Cited by 120
Shimizu, K., Yoshida, J., Nagai, K., Nishimura, M., Yokose, T., Ishii, G., & Nishiwaki, Y. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2003.11.017 · Cited by 113
Wistuba, I. I., Behrens, C., Lombardi, F., Wagner, S., Fujimoto, J., Raso, M. G., Spaggiari, L., Galetta, D., Riley, R., Hughes, E., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0596 · Cited by 113
Carbone, D. P., Ding, K., Röder, H., Grigorieva, J., Roder, J., Tsao, M., Seymour, L., & Shepherd, F. A. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826c1155 · Cited by 108
Ou, S. ‐. I., Zell, J. A., Ziogas, A., & Anton‐Culver, H. (2008) · Cancer · doi:10.1002/cncr.23397 · Cited by 98
The effect of comorbidity on stage-specific survival in resected non-small cell lung cancer patients
Lüchtenborg, M., Jakobsen, E. H., Krasnik, M., Linklater, K. M., Mellemgaard, A., & Møller, H. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2012.06.012 · Cited by 88
Brahmer, J. R., Horn, L., Gandhi, L., Spigel, D. R., Antonia, S. J., Rizvi, N. A., Powderly, J. D., Heist, R. S., Carvajal, R. D., Jackman, D. M., et al. (2014) · Journal of Clinical Oncology · doi:10.1200/jco.2014.32.15_suppl.8112 · Cited by 79
Gong, W., Zhang, X., Wu, J., Chen, L., Li, L., Sun, J., Lv, Y., Wei, X., Du, Y., Jin, H., et al. (2011) · Lung Cancer · doi:10.1016/j.lungcan.2011.08.003 · Cited by 79
Grossi, F., Loprevite, M., Chiaramondia, M., et al. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(03)00232-6 · Cited by 78
Anagnostou, V., Lowery, F. J., Zolota, V., Tzelepi, V., Gopinath, A., Liceaga, C., Παναγόπουλος, Ν., Frangia, K. B., Tanoue, L. T., Boffa, D. J., et al. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-186 · Cited by 74
Methylation Markers of Early-Stage Non-Small Cell Lung Cancer
Lokk, K., Vooder, T., Kolde, R., Välk, K., Võsa, U., Roosipuu, R., Milani, L. A., Fischer, K., Koltšina, M., Urgard, E., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039813 · Cited by 64
Carnio, S., Novello, S., Papotti, M. G., Iacono, M. L., & Scagliotti, G. V. (2013) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2013.10.05 · Cited by 62
Prognostic markers in lung cancer: is it ready for prime time?
Zhu, C., & Tsao, M. (2014) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2218-6751.2014.06.09 · Cited by 59
Understanding Prognostic Gene Expression Signatures in Lung Cancer
Zhu, C., Pintilie, M., John, T., Strumpf, D., Shepherd, F. A., Der, S. D., Jurišica, I., & Tsao, M. (2009) · Clinical Lung Cancer · doi:10.3816/clc.2009.n.045 · Cited by 55
Stinchcombe, T. E., Roder, J., Peterman, A. H., Grigorieva, J., Lee, C. B., Moore, D. T., & Socinski, M. A. (2013) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e3182835577 · Cited by 51
Molecular alterations in non–small cell lung carcinomas of the young
VandenBussche, C. J., Illei, P. B., Lin, M., Ettinger, D. S., & Maleki, Z. (2014) · Human Pathology · doi:10.1016/j.humpath.2014.08.005 · Cited by 44
van Laar, R. K. (2012) · BMC Medical Genomics · doi:10.1186/1755-8794-5-30 · Cited by 41
Details and Difficulties Regarding the New Lung Cancer Staging System
Detterbeck, F. C., Boffa, D. J., Tanoue, L. T., & Wilson, L. D. (2010) · CHEST Journal · doi:10.1378/chest.09-2626 · Cited by 41
Levels of cell-free DNA and plasma KRAS during treatment of advanced NSCLC
Nygaard, A. D., Spindler, K. G., Pallisgaard, N., Andersen, R. F., & Jakobsen, A. K. M. (2013) · Oncology Reports · doi:10.3892/or.2013.2906 · Cited by 38
Zheng, C., Qiu, C., Shen, M., Qu, X. H., Zhang, T., Zhang, J.-H., & Du, J. (2015) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2015.16.5.1881 · Cited by 31
Yang, Y., Xie, Y., & Xian, L. (2013) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-32-15 · Cited by 27
Kratz, J. R., Tham, P. T., Mulvihill, M. S., Ziaei, F., Ray, M., Hurst, J. W., Segal, M. R., Berryman, D. M., Chu, W., He, B., et al. (2013) · Diagnostic Molecular Pathology · doi:10.1097/pdm.0b013e318273fb61 · Cited by 26
Self-citationAgulló-Ortuño, M. T., Díaz-García, C. V., Agudo-López, A., Pérez, C., Cortijo, A., Paz-Ares, L. G., López‐Ríos, F., Pozo, F., de Castro, J., Cortés-Funes, H., et al. (2014) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-014-1787-z · Cited by 20
Zhao, X., He, Y., Gao, J., Zhao, C., Zhang, L., Tian, J., & Chen, H. (2014) · Asian Pacific Journal of Cancer Prevention · doi:10.7314/apjcp.2014.15.20.8861 · Cited by 15
Tran, T., Selinger, C. I., Yu, B., et al. (2014) · Journal of Clinical Pathology · doi:10.1136/jclinpath-2014-202347 · Cited by 15
[Expression and significance of gp96 and immune-related gene CTLA-4, CD8 in lung cancer tissues].
Zheng, H., Li, Y., Wang, X., Zhang, X., & Wang, X. (2010) · Europe PMC (PubMed Central) · doi:10.3779/j.issn.1009-3419.2010.08.08 · Cited by 9
Metadata
- Authors
- Woodard, G. A., Jones, K. D., & Jablons, D. M.
- Venue
- Cancer Treatment and Research
- Publisher
- Springer International Publishing
- Published
- 2016
- Volume
- 170
- Pages
- 47-75
- ISSN
- 0927-3042 (ISSN-L)
- 2509-8497
- OpenAlex
- W2515969222
- Cited by
- 366
- References
- 88
- FWCI
- 112.12
- Type
- book chapter
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.